Pulmonary surfactant exogenous in adults with acute respiratory distress syndrome;Surfactante pulmonar exógeno en adultos con síndrome de dificultad respiratoria aguda

Neumologia y Cirugia de Torax(Mexico)

Volumn 74, Issue 3, 2015, Pages 176-178

  Barrese Pérez, Yinet ^a,a   Hidalgo Sánchez, Angela Olga ^b   Ávila Albuerne, Yisel ^a   Uranga Piña, Rolando ^a   Díaz Casañas, Elaine ^c   Fernández Limia, Octavio ^c  

^a Centro Nacional Coordinador de Ensayos Clínicos CENCEC   (Cuba)

^b MINISTERIO DE SALUD PÚBLICA   (Cuba)

^c CENTRO NACIONAL DE SANIDAD AGROPECUARIA CENSA   (Cuba)

Author keywords

Acute respiratory distress syndrome; Adults; Exogenous surfactant

Indexed keywords

LUNG SURFACTANT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CLINICAL ARTICLE; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY; MULTICENTER STUDY; OXYGENATION; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT PARAMETERS; THORAX RADIOGRAPHY; VENTILATION MECHANICS;

EID: 84949805282     PISSN: 00283746     EISSN: 25941526     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2(7511):319-323.
2. Bernard GR, Artigas A, Brigham KL, et al. The American- European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-824.
3. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526-2533. doi: 10.1001/jama.2012.5669.
4. Costa EL, Amato MB. The new definition for acute lung injury and acute respiratory distress syndrome: is there room for improvement? Curr Opin Crit Care 2013;19(1):16-23. doi: 10.1097/MCC.0b013e32835c50b1.
5. Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 2013;41(5):1167-1174. doi: 10.1097/CCM.0b013e31827c09f8.
6. Goyal M, Houseman D, Johnson NJ, Christie J, Mikkelsen ME, Gaieski DF. Prevalence of acute lung injury among medical patients in the emergency department. Acad Emerg Med 2012;19(9):E1011-1018. doi: 10.1111/j.1553-2712.2012.01429.x.
7. Mikkelsen ME, Shah CV, Meyer NJ, et al. The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis. Shock 2013;40(5):375-381. doi: 10.1097/SHK.0b013e3182a64682.
8. Villar J, Blanco J, Kacmarek RM. Acute respiratory distress syndrome definition: do we need a change? Curr Opin Crit Care 2011;17(1):13-17. doi: 10.1097/MCC.0b013e32834271fb.
9. Saharan S, Lodha R, Kabra SK. Management of acute lung injury/ARDS. Indian J Pediatr 2010;77(11):1296-302. doi: 10.1007/s12098-010-0169-z.
10. Raghavendran K, Willson D, Notter RH. Surfactant therapy for acute lung injury and acute respiratory distress syndrome. Crit Care Clin 2011;27(3):525-559. doi: 10.1016/j.ccc.2011.04.005.
11. Manzanares TD, Díaz CE, Alfonso Lorenzo WC, et al. Centro Nacional de Sanidad Agropecuaria. Surfactante pulmonar natural de origen porcino. Patente de la República de Cuba A61K 35/42.1997 Dic 24.
12. Kesecioglu J, Beale R, Stewart TE, et al. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2009;180(10):989-994. doi: 10.1164/rccm.200812-1955OC.
13. Brown LM, Kallet RH, Matthay MA, Dicker RA. The influence of race on the development of acute lung injury in trauma patients. Am J Surg 2011;201(4):486-491. doi: 10.1016/j.amjsurg.2010.02.003.
14. Spragg RG, Lewis JF, Wurst W, et al. Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med 2003;167(11):1562-1566.
15. Willson DF, Thomas NJ, Markovitz BP, et al.; Pediatric Acute Lung Injury and Sepsis Investigators. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 2005;293(4):470-476.
16. Amital A, Shitrit D, Raviv Y, et al. The use of surfactant in lung transplantation. Transplantation 2008;86(11):1554-1559. doi: 10.1097/TP.0b013e31818a8418.
17. Taut FJ, Rippin G, Schenk P, et al. A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute). Chest 2008;134(4):724-732. doi: 10.1378/chest.08-0362.
18. Delfín BCA, Rodríguez ÁA. Administración del surfactante exógeno en el síndrome de distress respiratorio agudo. Rev Cub Med Int Emerg 2005;5(1):1-13.
19. Sánchez RC, Torres TJ. Surfactante pulmonar. Rev Ped Elec (en línea) 2004;1(1):45-50. ISSN 0718-0918
20. Rodríguez MVS, Prince MIA, Loret de Mola BY, Díaz CE. Uso de surfactante exógeno en un caso pediátrico de insuficiencia respiratoria aguda hipoxémica: presentación de un caso. AMC [revista en línea]. 2014;18(1):100-109. Fecha de consulta: 22 de febrero, 2015. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552014000100011&lng=es.
21. Villar J, Blanco J, Añón JM, et al.; ALIEN Network. The ALIEN study: Incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med 2011;37(12):1932-1941. doi: 10.1007/s00134-011-2380-4.
22. Kesecioglu J, Schultz M, Lundberg D, Lauven P, Lachmann B. Treatment of acute lung injury (ALI/ARDS) with surfactant [abstract]. Am J Respir Crit Care Med 2001;163:A819.
23. Kesecioglu J, Schultz M, Maas J, De Wilde R, Steenken E, Lachmann B. Treatment of acute lung injury and ARDS with surfactant is safe [abstract]. Am J Respir Crit Care Med 2004;169:A349.
24. Willson DF, Thomas NJ, Tamburro R, et al.; Pediatric Acute Lung and Sepsis Investigators Network. Pediatric calfactant in acute respiratory distress syndrome trial. Pediatr Crit Care Med 2013;14(7):657-665. doi: 10.1097/PCC.0b013e3182917b68.